D. McLachlan

发表

Family with 22-derived marker chromosome and late-onset dementia of the Alzheimer type: II. Further cytogenetic analysis of the marker and characterization of the high-level repeat sequences using fluorescence in situ hybridization.

M. Somerville, E. Jabs, D. Miller, 1993, American journal of medical genetics.

Age-associated chromosome 21 loss in Down syndrome: possible relevance to mosaicism and Alzheimer disease.

M. Somerville, A. Dalton, M. Percy, 1993, American journal of medical genetics.

Localization of a new ferritin heavy chain sequence present in human brain mRNA to chromosome 11.

M. Percy, J. Joshi, M. Dhar, 1995, Genome.

Alzheimer's disease in Down's syndrome

H. Wiśniewski, K. Wisniewski, A. Dalton, 1985, Neurology.

Molecular Genetic Evidence for Etiologic Heterogeneity of Alzheimer’s Disease

D. Pollen, J. Haines, E. Rogaev, 1992 .

Alzheimer's disease in Down's syndrome: Clinicopathologic studies

G. Wen, D. McLachlan, H. Wisniewski, 2011, Neurology.

Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories

C. Bergeron, D. McLachlan, J. Smith, 1996, Neurology.

Intramuscular desferrioxamine in patients with Alzheimer's disease

D. McLachlan, T. Kruck, W. Kalow, 1991, The Lancet.

Atypical presentation of progressive supranuclear palsy

C. Bergeron, D. McLachlan, P. H. Davis, 1985, Annals of neurology.

Nuclear compartmentalization of aluminum in Alzheimer's disease (AD)

W. Lukiw, T. Kruck, L. Wong, 1992, Neurobiology of Aging.

Machado-Joseph disease in pedigrees of Azorean descent is linked to chromosome 14.

J. Haines, E. Rogaev, P. S. St George-Hyslop, 1994, American journal of human genetics.

A Family with Multiple Instances of Definite, Probable and Possible Early-Onset Alzheimer's Disease

M. Percy, R. Becker, H. Karlinsky, 1991, British Journal of Psychiatry.

Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder

I. Rainero, J. L. Haines, J. A. Hardy, 1990, Nature.

Anomalous Gene Expression in Alzheimer Disease: Cause or Effect

M. Somerville, C. Mizzen, L. Wong, 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment

W. Snow, M. Tierney, J. Szalai, 1996, Neurology.

Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium?

M. Freedman, D. Pollen, J. Haines, 1994, Annals of neurology.

Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.

A. Dalton, M. Percy, D. Andrews, 1990, American journal of medical genetics.

Reduction of thyroid hormone receptor c-ERB Aα mRNA levels in the hippocampus of Alzheimer as compared to huntington brain

M. Somerville, P. Handley, L. Wong, 1992, Neurobiology of Aging.

Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidence.

P. Fraser, A. Dalton, D. McLachlan, 1992, Ciba Foundation symposium.

Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β‐amyloid precursor protein gene

J. Haines, P. S. St George-Hyslop, R. Tanzi, 1992, Neurology.

Localization of the 68,000-Da human neurofilament gene (NF68) using a murine cDNA probe.

M. Somerville, M. Percy, D. McLachlan, 1988, Genome.